Adage Capital Partners, L.P., 10% Owner at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 307,128 shares at $96.61 ($28.0M) on 2017-06-05, disclosed to the SEC on 2017-06-05.
Open-market sale of $28.0M PBYI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.32 | 1,100 | $94K | 0.3% |
| 2 | $88.12 | 63,227 | $5.6M | 19.9% |
| 3 | $90.21 | 152,762 | $13.8M | 49.2% |
| 4 | $91.31 | 23,272 | $2.1M | 7.6% |
| 5 | $92.00 | 3,083 | $284K | 1.0% |
| 6 | $96.61 | 52,016 |
| $5.0M |
| 17.9% |
| 7 | $99.08 | 11,668 | $1.2M | 4.1% |
| Total | $91.28 avg | 307,128 | $28.0M | 100% |
| Filing → |
| ORBC | SELL | 2019-11-22 | $996K | — | Filing → |
| PBYI | SELL | 2017-06-05 | $43.8M | — | Filing → |
| PBYI | SELL | 2017-06-05 | $14.0M | — | Filing → |